Literature DB >> 14702154

Pathogen-specific induction of CD154 is impaired in CD4+ T cells from human immunodeficiency virus-infected patients.

Carlos S Subauste1, Matthew Wessendarp, Jose-Andres C Portilllo, Rosa M Andrade, Linda M Hinds, Francisco J Gomez, A George Smulian, Peter A Grubbs, Lisa A Haglund.   

Abstract

The pathogenesis of immunodeficiency associated with human immunodeficiency virus (HIV) infection remains incompletely understood. CD154, a molecule that is expressed primarily on activated CD4(+) T cells, is pivotal for regulation of cell-mediated and humoral immunity and is crucial for control of many opportunistic infections. We investigated whether CD4(+) T cells from HIV-infected patients exhibit defective induction of CD154 in response to opportunistic pathogens. Incubation of purified human CD4(+) T cells with monocytes plus antigenic preparations of either Candida albicans, cytomegalovirus, or Toxoplasma gondii resulted in induction of CD154. Expression of CD154 in response to these pathogens was impaired in CD4(+) T cells from HIV-infected patients. This defect correlated with decreased production of interleukin (IL)-12 and interferon (IFN)-gamma in response to T. gondii. Recombinant CD154 partially restored secretion of IL-12 and IFN-gamma in response to T. gondii in cells from HIV-infected patients. Together, defective induction of CD154 is likely to contribute to impaired cell-mediated immunity against opportunistic pathogens in HIV-infected patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14702154     DOI: 10.1086/380510

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Highly active antiretroviral therapy in patients infected with human immunodeficiency virus increases CD40 ligand expression and IL-12 production in cells ex vivo.

Authors:  Alice M Nyakeriga; Jun Ying; Norah J Shire; Carl J Fichtenbaum; Claire A Chougnet
Journal:  Viral Immunol       Date:  2011-08       Impact factor: 2.257

2.  Failure of HIV-exposed CD4+ T cells to activate dendritic cells is reversed by restoration of CD40/CD154 interactions.

Authors:  Rui Zhang; Jeffrey D Lifson; Claire Chougnet
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

3.  Control of Mycobacterium tuberculosis growth by activated natural killer cells.

Authors:  C Guerra; K Johal; D Morris; S Moreno; O Alvarado; D Gray; M Tanzil; D Pearce; V Venketaraman
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

4.  Expression of CD154 by a simian immunodeficiency virus vector induces only transitory changes in rhesus macaques.

Authors:  Vida L Hodara; M Cristina Velasquillo; Laura M Parodi; Luis D Giavedoni
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

5.  CD40 signaling in macrophages induces activity against an intracellular pathogen independently of gamma interferon and reactive nitrogen intermediates.

Authors:  Rosa M Andrade; Jose-Andres C Portillo; Matthew Wessendarp; Carlos S Subauste
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

6.  Expression of cutaneous lymphocyte-associated antigen and E-selectin ligand by circulating human memory CD4+ T lymphocytes specific for herpes simplex virus type 2.

Authors:  Julio C González; William W Kwok; Anna Wald; Christopher L McClurkan; Jay Huang; David M Koelle
Journal:  J Infect Dis       Date:  2004-12-15       Impact factor: 5.226

Review 7.  CD40 and the immune response to parasitic infections.

Authors:  Carlos S Subauste
Journal:  Semin Immunol       Date:  2009-07-18       Impact factor: 11.130

8.  Glucocorticoid-induced tumor necrosis factor receptor family-related protein triggering enhances HIV-specific CD4+ T cell cytokine secretion and protects HIV-specific CD4+ T cells from apoptosis.

Authors:  Timothy P Lahey; Suzanne D Loisel; Wendy Wieland-Alter
Journal:  J Infect Dis       Date:  2007-05-23       Impact factor: 5.226

9.  Identification of primary retinal cells and ex vivo detection of proinflammatory molecules using flow cytometry.

Authors:  Jose-Andres C Portillo; Genevieve Okenka; Timothy S Kern; Carlos S Subauste
Journal:  Mol Vis       Date:  2009-07-17       Impact factor: 2.367

10.  Construction of a high titer infectious HIV-1 subtype C proviral clone from South Africa.

Authors:  Graeme B Jacobs; Stefanie Bock; Anita Schuch; Rebecca Moschall; Eva-Maria Schrom; Juliane Zahn; Christian Reuter; Wolfgang Preiser; Axel Rethwilm; Susan Engelbrecht; Thomas Kerkau; Jochen Bodem
Journal:  Viruses       Date:  2012-09-24       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.